Renal Calcitonin Amyloidosis in a Patient with Disseminated Medullary Thyroid Carcinoma
Ying Tan,Danyang Li,Tiantian Ma,Rong Xu,Fu-de Zhou,Suxia Wang,Minghui Zhao
DOI: https://doi.org/10.1080/13506129.2020.1738376
2020-01-01
Amyloid
Abstract:Renal amyloidosis is a frequent manifestation of systemic amyloidosis, which is one of the major causes of secondary nephrotic syndrome in elderly patients [1]. More than 30 different precursor proteins can cause amyloidosis [2]. (Pro)Calcitonin (ACal) amyloidosis usually manifests as a localised form in medullary thyroid carcinoma (MTC), and has been reported in one patient as systemic amyloidosis involving the kidney [3]. Here we describe a Chinese patient with disseminated MTC who presented with proteinuria and renal insufficiency caused by renal ACal amyloidosis. A 55-year-old Chinese woman underwent partial thyroid resection and cervical lymph node dissection for T1N1a stage MTC nine years ago, and ACal identified in the MTC specimens (Figure 1(A,B)). Chemotherapy was performed for two cycles, and she was monitored with a normal serum CEA level until 5 years later. She had a progressively elevated CEA (>1000mg/L), proteinuria of 2.88 g/24 h and mild renal dysfunction with serum creatinine (Scr) of 175lmol/L (44–133 lmol/L). She only took Chinese herbs in local hospitals. At admission to our hospital, her symptoms were nausea, vomiting, fatigue and diarrhoea, the Scr increased to 402lmol/L, the eGFR decreased to 10ml/min/ 1.73m, and proteinuria increased to as 3.91 g/24 h. Plasma calcitonin was over 2000 pg/mL (6.4-2000pg/mL) and the CEA level over 1000 ng/mL. The PET-CT scan showed suspected lung, bone and colon metastasis of MTC. The bone marrow biopsy confirmed bone metastasis of MTC. She did not have a familial history of MTC. No mutation of the RET gene for familial MTC was been identified by genomic DNA sequencing. When she was prepared to receive therapy with a tyrosine kinase inhibitor, she developed acute heart failure, epilepsy and severe pneumonia and died of diffuse intravascular coagulation and multiple organ failure two months later. Renal biopsy exhibited glomerular and arteriolar amyloid deposition (Figure 1(C)), with the yellow-green birefringence of Congo red staining under polarised light, and electron microscopy demonstrated randomly nonbranching fibrils with a diameter of 8-10 nm deposited in glomerular mesangium and the subendothelium of the glomerular basement membrane. Immunohistochemistry (IHC) showed that the glomerular and arteriolar amyloid deposits were strongly positive for calcitonin (Figure 1(D)), but negative for jand k-light chains, amyloid A protein (Figure 1(E)), lysozyme, LECT2, Apo-A-I, fibrinogen Aa and transthyretin. In addition, there were a few spindle cells in the focal tubulointerstitium, which were positive for calcitonin by IHC, suggesting renal interstitial metastasis of MTC cells (Figure 1(F)). Renal amyloid typing was further performed by laser microdissection and mass spectrometry (LMD-MS). Amyloid signature proteins, including apolipoprotein A-IV, apolipoprotein E and serum amyloid P, were identified. The sequences for procalcitonin (2 unique peptides and 3 spectra) and calcitonin (1 unique peptide and 10 spectra) were detected, indicating that the amyloid proteins contained both procalcitonin and calcitonin (Figure 2). In this case report, we identified renal ACal in a patient with disseminated MTC. The patient did not have a familial